|
1
|
Mozaffarian D: Trans fatty acids-effects
on systemic inflammation and endothelial function. Atheroscler
Suppl. 7:29–32. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang J, Wu G and Dai H: The matricellular
protein CCN1 regulates TNF-α induced vascular endothelial cell
apoptosis. Cell Biol Int. 40:1–6. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nilsson J: Atherosclerosis-the molecular
background. Lakartidningen. 88:127–129. 1991.(In Swedish).
PubMed/NCBI
|
|
4
|
Tada H, Takamura M and Kawashiri MA: What
is the mechanism of genetic contributions to the development of
atherosclerosis? Atherosclerosis. 307:72–74. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Emre Y and Imhof BA: Matricellular protein
CCN1/CYR61: A new player in inflammation and leukocyte trafficking.
Semin Immunopathol. 36:253–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wong M, Kireeva ML, Kolesnikova TV and Lau
LF: Cyr61, product of a growth factor-inducible immediate-early
gene, regulates chondrogenesis in mouse limb bud mesenchymal cells.
Dev Biol. 192:492–508. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao JF, Chen HY, Wei J, Jim Leu SJ and
Lee TS: CCN family member 1 deregulates cholesterol metabolism and
aggravates atherosclerosis. Acta Physiol (Oxf). 225:e132092019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mielenz M: Invited review:
Nutrient-sensing receptors for free fatty acids and
hydroxycarboxylic acids in farm animals. Animal. 11:1008–1016.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Briggs MA, Petersen KS and Kris-Etherton
PM: Saturated fatty acids and cardiovascular disease: Replacements
for saturated fat to reduce cardiovascular risk. Healthcare
(Basel). 5:292017. View Article : Google Scholar
|
|
10
|
Yang L, Guan G, Lei L, Lv Q, Liu S, Zhan
X, Jiang Z and Gu X: Palmitic acid induces human osteoblast-like
Saos-2 cell apoptosis via endoplasmic reticulum stress and
autophagy. Cell Stress Chaperones. 23:1283–1294. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miyamoto J, Hasegawa S, Kasubuchi M,
Ichimura A, Nakajima A and Kimura I: Nutritional signaling via free
fatty acid receptors. Int J Mol Sci. 17:4502016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang H, Liang C, Liu X, Jiang Q, He Z, Wu
J, Pan X, Ren Y, Fan M, Li M and Wu Z: Palmitic acid promotes
endothelial progenitor cells apoptosis via p38 and JNK
mitogen-activated protein kinase pathways. Atherosclerosis.
210:71–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leroy C, Tricot S, Lacour B and Grynberg
A: Protective effect of eicosapentaenoic acid on palmitate-induced
apoptosis in neonatal cardiomyocytes. Biochim Biophys Acta.
1781:685–693. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Liu L, Palacios G, Gao J, Zhang N,
Li G, Lu J, Song T, Zhang Y and Lv H: Plasma metabolomics reveals
biomarkers of the atherosclerosis. J Sep Sci. 33:2776–2783. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Geng J, Xu H, Yu X, Xu G, Cao H, Lin G and
Sui D: Rosuvastatin protects against oxidized low-density
lipoprotein-induced endothelial cell injury of atherosclerosis
in vitro. Mol Med Rep. 19:432–440. 2019.PubMed/NCBI
|
|
16
|
Chen P, Liu H, Xiang H, Zhou J, Zeng Z,
Chen R, Zhao S, Xiao J, Shu Z, Chen S and Lu H: Palmitic
acid-induced autophagy increases reactive oxygen species via the
Ca2+/PKCα/NOX4 pathway and impairs endothelial function
in human umbilical vein endothelial cells. Exp Ther Med.
17:2425–2432. 2019.PubMed/NCBI
|
|
17
|
Tajadura V, Hansen MH, Smith J, Charles H,
Rickman M, Farrell-Dillon K, Claro V, Warboys C and Ferro A:
β-catenin promotes endothelial survival by regulating eNOS activity
and flow-dependent anti-apoptotic gene expression. Cell Death Dis.
11:4932020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma S, Yao S, Tian H, Jiao P, Yang N, Zhu P
and Qin S: Pigment epithelium-derived factor alleviates endothelial
injury by inhibiting Wnt/beta-catenin pathway. Lipids Health Dis.
16:312017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ali H, Zmuda JM, Cvejkus RK, Kershaw EE,
Kuipers AL, Oczypok EA, Wheeler V, Bunker CH and Miljkovic I: Wnt
pathway inhibitor DKK1: A potential novel biomarker for adiposity.
J Endocr Soc. 3:488–495. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mo FE and Lau LF: The matricellular
protein CCN1 is essential for cardiac development. Circ Res.
99:961–969. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsu PL, Chen JS, Wang CY, Wu HL and Mo FE:
Shear-induced CCN1 promotes atheroprone endothelial phenotypes and
atherosclerosis. Circulation. 139:2877–2891. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lau LF: CCN1/CYR61: The very model of a
modern matricellular protein. Cell Mol Life Sci. 68:3149–3163.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jun JI and Lau LF: Taking aim at the
extracellular matrix: CCN proteins as emerging therapeutic targets.
Nat Rev Drug Discov. 10:945–963. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Otsuka F, Finn AV, Yazdani SK, Nakano M,
Kolodgie FD and Virmani R: The importance of the endothelium in
atherothrombosis and coronary stenting. Nat Rev Cardiol. 9:439–453.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Daiber A, Xia N, Steven S, Oelze M, Hanf
A, Kröller-Schön S, Münzel T and Li H: New therapeutic implications
of endothelial nitric oxide synthase (eNOS) Function/Dysfunction in
cardiovascular disease. Int J Mol Sci. 20:1872019. View Article : Google Scholar
|
|
27
|
Ju L, Sun Y, Xue H, Chen L, Gu C, Shao J,
Lu R, Luo X, Wei J, Ma X and Bian Z: CCN1 promotes hepatic
steatosis and inflammation in non-alcoholic steatohepatitis. Sci
Rep. 10:32012020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ghosh A, Gao L, Thakur A, Siu PM and Lai
CWK: Role of free fatty acids in endothelial dysfunction. J Biomed
Sci. 24:502017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hadi HA, Carr CS and Al Suwaidi J:
Endothelial dysfunction: Cardiovascular risk factors, therapy, and
outcome. Vasc Health Risk Manag. 1:183–198. 2005.PubMed/NCBI
|
|
30
|
Kaptoge S, Seshasai SR, Gao P, Freitag DF,
Butterworth AS, Borglykke A, Di Angelantonio E, Gudnason V, Rumley
A, Lowe GD, et al: Inflammatory cytokines and risk of coronary
heart disease: New prospective study and updated meta-analysis. Eur
Heart J. 35:578–589. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chiodoni C, Colombo MP and Sangaletti S:
Matricellular proteins: From homeostasis to inflammation, cancer,
and metastasis. Cancer Metastasis Rev. 29:295–307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen CC, Juric V and Lau LF: The
extracellular matrix protein CCN1 dictates TNFalpha and FasL
cytotoxicity in vivo. Adv Exp Med Biol. 691:595–603. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de Jaime-Soguero A, Abreu de Oliveira WA
and Lluis F: The pleiotropic effects of the canonical Wnt pathway
in early development and pluripotency. Genes (Basel). 9:932018.
View Article : Google Scholar
|
|
34
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin S, Zhen Y, Guan Y and Yi H: Roles of
Wnt/β-catenin signaling pathway regulatory long non-coding RNAs in
the pathogenesis of non-small cell lung cancer. Cancer Manag Res.
12:4181–4191. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jia L, Piña-Crespo J and Li Y: Restoring
Wnt/β-catenin signaling is a promising therapeutic strategy for
Alzheimer's disease. Mol Brain. 12:1042019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Herr P and Basler K: Porcupine-mediated
lipidation is required for Wnt recognition by Wls. Dev Biol.
361:392–402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Foulquier S, Daskalopoulos EP, Lluri G,
Hermans KCM, Deb A and Blankesteijn WM: WNT signaling in cardiac
and vascular disease. Pharmacol Rev. 70:68–141. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li ZQ, Ding W, Sun SJ, Li J, Pan J, Zhao
C, Wu WR and Si WK: Cyr61/CCN1 is regulated by Wnt/β-catenin
signaling and plays an important role in the progression of
hepatocellular carcinoma. PLoS One. 7:e357542012. View Article : Google Scholar : PubMed/NCBI
|
